Correlation Between Exelixis and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Exelixis and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Fate Therapeutics, you can compare the effects of market volatilities on Exelixis and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Fate Therapeutics.
Diversification Opportunities for Exelixis and Fate Therapeutics
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Exelixis and Fate is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Exelixis and Fate Therapeutics
Given the investment horizon of 90 days Exelixis is expected to generate 0.3 times more return on investment than Fate Therapeutics. However, Exelixis is 3.39 times less risky than Fate Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.03 per unit of risk. If you would invest 1,659 in Exelixis on September 26, 2024 and sell it today you would earn a total of 1,723 from holding Exelixis or generate 103.86% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Exelixis vs. Fate Therapeutics
Performance |
Timeline |
Exelixis |
Fate Therapeutics |
Exelixis and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Exelixis and Fate Therapeutics
The main advantage of trading using opposite Exelixis and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Exelixis vs. Fate Therapeutics | Exelixis vs. Caribou Biosciences | Exelixis vs. Karyopharm Therapeutics | Exelixis vs. Hookipa Pharma |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |